Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
angela.santoni@uniroma1.it
Angela Santoni
Lavoratore autonomo
Struttura:
Scuola di Studi Avanzati della Sapienza - SSAS
E-mail:
angela.santoni@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells. role of cMYC-IRF4-miR-125b interplay
JOURNAL OF HEMATOLOGY & ONCOLOGY
2016
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells
ONCOIMMUNOLOGY
2016
Regulation of NKG2D Expression and Signaling by Endocytosis
TRENDS IN IMMUNOLOGY
2016
NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2
IMMUNOLOGY LETTERS
2016
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression
JOURNAL OF IMMUNOLOGY
2016
Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients.
ONCOTARGET
2016
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases.
FRONTIERS IN IMMUNOLOGY
2016
Targeting NKG2D and NKp30 ligands shedding to improve NK cell–based immunotherapy
CRITICAL REVIEWS IN IMMUNOLOGY
2016
Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice
Nature CommunicationsNATURE COMMUNICATIONS
2015
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients
ONCOIMMUNOLOGY
2015
NK cells and interferons
CYTOKINE & GROWTH FACTOR REVIEWS
2015
Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.
HAEMATOLOGICA
2015
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
BIOMED RESEARCH INTERNATIONAL
2015
The multifaceted role of PIP2 in leukocyte biology
CELLULAR AND MOLECULAR LIFE SCIENCES
2015
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma
ONCOTARGET
2015
Response to comment on multifunctional human CD56<sup>low</sup>CD16<sup>low</sup> NK cells are the prominent subset in bone marrow of both pediatric healthy donors and leukemic patients
HAEMATOLOGICA
2015
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells
CANCER RESEARCH
2015
In Vivo Imaging of Natural Killer Cell Trafficking in Tumors
THE JOURNAL OF NUCLEAR MEDICINE
2015
The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro
JOURNAL OF IMMUNOTHERAPY
2015
Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells.
ONCOTARGET
2015
« prima
< precedente
1
2
3
4
5
6
7
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma